Hisamitsu Pharmaceutical (Japan) Menopausal Syndrome Patch for Women, 0.72 mg: 70 patches

1
SKU: N/A
HKD$720.00 Original price was: HKD$720.00.HKD$681.00Current price is: HKD$681.00.
In Stock
WhatsApp Product Inquiry
Add to wishlist
Compare
Free shipping on orders over HKD $500, USD $200, or CNY ¥500.
Delivery within 4–7 business days.
Money Back Guarantee
No shipping on Sat, Sun & Japanese national holidays.

描述

Direct overseas shipping (Direct shipping from Japan)

Estrana Tape 0.09 mg/0.18 mg/0.36 mg/0.72 mg
ESTRANA Tapes

Japan Standard Commodity Classification Code 872473 | Revised October 2025 (5th Edition) / Revised May 2023 (4th Edition)

A transdermal estradiol preparation indicated for menopausal disorders and symptoms of ovarian insufficiency (vasomotor symptoms such as hot flashes and sweating, as well as urogenital atrophy), postmenopausal osteoporosis, and hypogonadism, among other conditions characterized by low estrogen levels. Transdermal application maintains stable blood levels and avoids first-pass metabolism in the liver.

ESTRANA

Product Details / Approval Status, etc.

Japan Standard Commodity Classification Code 872473
Pharmacological Classification Name Transdermal Estradiol Preparations
General Name Transdermal estradiol preparation
Estradiol Transdermal Preparation
Product Name Estrana Tape 0.09 mg/0.18 mg/0.36 mg/0.72 mg
ESTRANA Tapes
YJ Code 0.09 mg: 2473700S5024
0.18 mg: 2473700S6020
0.36 mg: 2473700S7027
0.72 mg: 2473700S2076
Approval Number 0.09 mg: 22700AMX00357000
0.18 mg: 22700AMX00356000
0.36 mg: 22700AMX00355000
0.72 mg: 21900AMX01357000
Sales Begin 0.09/0.18/0.36 mg: September 2015
0.72 mg: February 2000
Storage Instructions / Expiration Date Room temperature (avoid high temperatures) / 2.5 years
Regulatory Classification Prescription drugs (to be used as prescribed by a physician or other healthcare professional)
Manufacturing and Sales Yuan Hisamitsu Pharmaceutical Co., Ltd.
408 Tashiro-Ōkan-chō, Tosu City
Packaging 0.09/0.18 mg: 35 tablets [(7 tablets/bag) × 5 bags]
0.36/0.72 mg: 70 or 140 tablets [(1 tablet per packet)]

1. Composition and Properties (3.)

3.1 Composition
Active ingredient: Estradiol 0.09/0.18/0.36/0.72 mg per patch
Ingredients: Clotrimazole, butylated hydroxytoluene, hydrogenated rosin glyceryl ester, styrene-isoprene-styrene block copolymer, polyisobutylene, liquid paraffin, and one other ingredient

3.2 Characteristics of the Preparation
An oval-shaped tape preparation consisting of a colorless ointment spread onto a light orange-colored backing
0.09 mg: 13.0 mm (long) × 11.0 mm (short) (1.125 cm²) Identification Code: HP374T
0.18 mg: Length 18.5 mm × Width 15.5 mm (2.25 cm²) Identification Code HP373T
0.36 mg: 26.1 mm (long) × 22.0 mm (short) (4.5 cm²) Identification Code: HP372T
0.72 mg: Length 37.0 mm × Width 31.0 mm (9 cm²) Identification Code HP371T

2. Efficacy or Effect (4.)

General Principles of Drug Formulation
・Vasomotor symptoms (hot flashes and sweating) associated with menopausal disorders and ovarian insufficiency; urogenital atrophic symptoms
・Postmenopausal Osteoporosis
・Hypogonadism, hypogonadism resulting from gonadectomy, or hypoestrogenism caused by primary ovarian insufficiency

0.72 mg: Adjustments to the Timing of Ovarian Stimulation in Assisted Reproductive Technology

0.36 mg / 0.72 mg: Hormone Replacement Cycle for Frozen-Thawed Embryo Transfer

3. Directions and Dosage (6.)

Menopausal Symptoms, Symptoms of Ovarian Insufficiency, Postmenopausal Osteoporosis
Typically, adults apply a 0.72 mg estradiol patch to the lower abdomen or buttocks, changing it every two days.

Hypoestrogenism, such as hypogonadism
For adults, start with 0.72 mg, change the dose every 2 days, and adjust the dose up or down based on symptoms. For children, start with 0.09 mg and increase the dose in stages: 0.18 → 0.36 → 0.72 mg.

Adjusting the Start Time of Ovarian Stimulation
0.72 mg; apply for 21–28 days, changing the patch every 2 days; use in combination with progesterone during the second half of the cycle.

Hormone Replacement Cycle for Frozen-Thawed Embryo Transfer
0.72–5.76 mg transdermal patch; once the endometrium has thickened sufficiently, combine with progesterone until 8 weeks of pregnancy (not to exceed 10 weeks).

4. Contraindications and Precautions for Patients with Specific Conditions (2./9.)

Major Contraindications
Estrogen-dependent malignant tumors (such as breast cancer and endometrial cancer) and suspected cases thereof; history of breast cancer; untreated endometrial hyperplasia; thrombophlebitis; / history of pulmonary embolism, history of arterial thromboembolic disease, allergy to any component, lactating women, severe hepatic impairment, unexplained abnormal genital bleeding of undetermined cause, pregnant women, or women who may be pregnant.

Notes
Caution is advised for patients with uterine fibroids, endometriosis, a strong family history of breast cancer, hypertension or heart disease, diabetes, migraines or epilepsy, those who are preoperative or bedridden for extended periods, systemic lupus erythematosus, kidney disease, or liver dysfunction. A medical history review, breast examination, and gynecological examination must be performed before use, and regular follow-up is required during treatment.

5. Side Effects (11.)

Serious Adverse Effects(Frequency unknown)
Anaphylaxis, venous thromboembolism, thrombophlebitis (discontinue use immediately if early symptoms such as pain or swelling in the lower limbs, chest pain, sudden shortness of breath, or visual disturbances occur).

Other Side Effects
Skin: Acute irritant contact dermatitis (erythema, itching, etc., 5% or higher), blisters, hyperpigmentation, etc.
Genital System: Abnormal bleeding, withdrawal bleeding (5% or higher), vaginal discharge, a sensation of swelling in the vulva, etc.
Breasts: Breast tenderness (5% or higher), breast pain, mastopathy, etc.
Other: Headaches, edema, abnormal liver function, weight gain, worsening varicose veins, etc.

6. Notes on Application (14.)

Application Sites and Methods
Apply to the lower abdomen or buttocks. Avoid the back, waistline, chest, or areas with wounds or dermatitis. Change the application site with each use. Apply after cleaning and drying the skin; do not cut the patch. Store any unused portions of the 0.09/0.18 mg patches in the folded bag opening and use within 30 days of opening.

7. Pharmacokinetics (16.)

In healthy postmenopausal women, a single 0.72 mg patch applied for 48 hours: Serum E2 concentrations remained at approximately 52.0–53.8 pg/mL from 8 to 12 hours after application until removal, and declined rapidly after removal (half-life of approximately 2 hours). After 7 repeated applications (14 days), steady state is achieved; the average concentration 48 hours after application is 52.5–60.5 pg/mL, with no tendency toward accumulation.

8. Clinical Results and Pharmacodynamics and Pharmacology (17./18.)

17. Clinical Results
Overall improvement in menopausal symptoms (moderate or greater): 86.51 TP3T; symptoms of ovarian insufficiency: 84.21 TP3T. Average increase in bone density for postmenopausal osteoporosis: 4.831 TP3T.

18. Pharmacodynamics and Pharmacology
Provides 17β-estradiol directly through the skin to maintain appropriate blood levels and alleviate symptoms of estrogen deficiency. When used in conjunction with progesterone during ovarian stimulation and hormone replacement therapy cycles, it helps regulate endometrial proliferation and secretory phase changes.

9. Physicochemical Properties of the Active Ingredient (19.)

Generic Name: Estradiol
Chemical Name: Estra-1,3,5(10)-triene-3,17β-diol
Molecular formula: C18H24O2 Molecular weight: 272.38
Appearance: White to slightly yellow crystals or crystalline powder; odorless. Melting point: 175–180°C.

※ This page is compiled from information in the package insert and is not a substitute for a doctor’s prescription or the original Japanese version. For details, please refer to the PMDA package insert.

[Disclaimer]

  1. The information regarding medications, treatments, or health management contained in this article is compiled from international authoritative medical journals and official clinical literature, and is intended for general science and educational reference only.
  2. The indications, side effects, and contraindications of related medications may vary depending on national regulations and individual physical conditions. Do not blindly take medication on your own or change your treatment plan.
  3. The author and publishing platform assume no legal liability for any medical delays, adverse reactions, or direct or indirect losses caused by the use of the information in this article. All medical decisions should be discussed with your attending physician before being made.

Additional information

Specifications

ESTRANA Estrana Tape 0.72 mg (70 patches)

1 review for 日本久光製藥 女性更年期綜合症膏貼 0.72mg:70枚

5.00

Average of 1 review

  1. 王 –

    OK

Add a review

Your email address will not be published. 必填欄位標示為 *

Recently viewed

14%
Add to wishlist
5.00

Nexium, a Premium Japanese Antacid: Esomeprazole Capsules 20 mg (100 capsules) for Stomach Ulcers, Acid Reflux, Duodenal Ulcers, and Reflux Esophagitis

Original price was: HKD$1,100.00.Current price is: HKD$956.00.
Select options This product has multiple variants. The options may be chosen on the product page
Add to wishlist
5.00

Eisai Japan Methycobal Yikebo Methycobal Tablets, Methylcobalamin 500 μg: 100 tablets; Treatment for Peripheral Neuropathy

HKD$280.00
Select options This product has multiple variants. The options may be chosen on the product page
Add to wishlist
Store
Search
Wishes
cart
Track
Account
Select currency

No products in the cart.

Copyright 2026 © Hkeemall. All rights reserved. |  Return and Exchange Policy  |  Privacy Policy  |  Contact us